Antonius van Dijk

Insider Reports History

Entity
Individual
Location
149 Fifth Avenue, Suite 500, New York, New York
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact for Marc Antonius van Dijk
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Antonius van Dijk:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MiNK Therapeutics, Inc. Chief Scientific Officer Stock Option 171K Jan 16, 2024 Direct

Insider Reports Filed by Antonius van Dijk

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INKT MiNK Therapeutics, Inc. Jan 16, 2024 2 $0 4 Jan 18, 2024 Chief Scientific Officer
INKT MiNK Therapeutics, Inc. Jan 9, 2023 2 $63.5K 4 Jan 12, 2023 Chief Scientific Officer
INKT MiNK Therapeutics, Inc. Jan 9, 2023 1 $0 4 Jan 11, 2023 Chief Scientific Officer
INKT MiNK Therapeutics, Inc. Jan 21, 2022 1 $0 4 Jan 25, 2022 Chief Technology Officer
INKT MiNK Therapeutics, Inc. Oct 13, 2021 0 $0 3 Oct 20, 2021 Chief Technology Officer